Adlai Nortye Ownership | Who Owns Adlai Nortye?
Adlai Nortye Ownership Summary
Adlai Nortye is owned by 108.71% institutional investors, 5.66% insiders. Tema Oncology ETF is the top mutual fund, with 0.07% of its assets in Adlai Nortye shares.
ANL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Adlai Nortye | 108.71% | 5.66% | -14.37% |
| Sector | Healthcare Stocks | 35.75% | 11.89% | 52.37% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 26 | 550.00% | 11,586,547 | 20659.96% | 108 | 39640.94% | 25 | 733.33% | - | -100.00% |
| Dec 31, 2025 | 4 | - | 55,812 | 243.18% | - | 2248.89% | 3 | 200.00% | 1 | -66.67% |
| Sep 30, 2025 | 4 | - | 16,263 | -72.75% | - | 48.52% | 1 | -75.00% | 3 | - |
| Jun 30, 2025 | 4 | - | 59,682 | 5.52% | - | 198.53% | 4 | 100.00% | - | -100.00% |
| Mar 31, 2025 | 4 | 33.33% | 56,560 | -0.58% | - | 185.97% | 2 | - | 1 | -66.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Tema Oncology ETF | 44.35K | 0.07% | - |
| Fidelity Nasdaq Composite Index | 11.13K | 0.02% | - |
| Telescope Biotech Fund A FIL | 8.95K | 0.01% | - |
| JHVIT Health Sciences I | 1.71K | 0.00% | 1.71K |
| EQ/T. Rowe Price Health Sciences IB | 1.21K | 0.00% | 1.21K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 13, 2026 | LU YANG | CEO | Sell | $131.80 |
| Apr 26, 2006 | BLATZ ROBERT G | President and COO | Sell | $20.21K |
| Apr 24, 2006 | BLATZ ROBERT G | President and COO | Sell | $13.47K |
| Apr 21, 2006 | BLATZ ROBERT G | President and COO | Sell | $13.51K |
| Apr 20, 2006 | BLATZ ROBERT G | President and COO | Sell | $13.47K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2029 Q1 | - | - |
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | - |
| 2024 Q3 | - | - |
| 2022 Q3 | - | - |
ANL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools